Identifying antibiotic-resistant Gram-negative bacteria

Apr 29, 2015

The new Streck Philisa ampC ID kit enables rapid identification of six plasmid-mediated ampC resistance genes for pathogen surveillance in hospitals and research. When used along with standard culture, this conventional polymerase chain reaction (PCR) kit will help to provide up-to-date information for infection control by identifying which Gram-negative ampC-resistant bacterial strains are present in the hospital. Resistance to the beta-lactam class of antimicrobials is a significant cause of multidrug-resistant urinary tract and bloodstream infections.

The Philisa ampC ID kit, available exclusively in the UK from Alpha Laboratories, is a PCR- based molecular test that detects six of the most common plasmid-mediated ampC gene families (MOX, DHA, ACC, EBC, FOX, CMY). It provides a result in one hour, compared to the two/three days taken by traditional disk-diffusion methods. An endogenous internal control reduces false-negative results.

The test involves a 15-minute PCR step, followed by agarose gel electrophoresis to resolve the PCR products. Their molecular masses are then compared against external controls to provide an indication of genotype. This gives a clear, positive identification of strain genotype and antimicrobial resistance (AMR) potential.

The increased incidence of antibiotic-resistant Gram-negative bacteria is of significant and growing concern. Treatment options for such bacteria are relatively limited and further restricted by the emergence of AMR. Resistance in Gram-negative species is usually associated with beta-lactamase enzymes, of which class C cephalosporinases (AmpC) is one of the best known. Thus, a proper understanding of the specific genotype and susceptibility of a given strain is the key to effective therapeutic intervention. [email protected]

Featured Supplier

InterSystems provides the information engines that power some of the world's most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems has been a strategic technology provider since 1978. InterSystems is a privately held company headquartered in Cambridge, Massachusetts...

Register NOW to receive regular copies of Pathlogy In Practice Free Of Charge

Don't miss out on the latest news affecting UK Pathology Services, Biomedical Scientists and Medical Laboratory Professionals. Register FREE for your regular copy of Pathology In Practice now, and enjoy FREE access to feature article content and to the digital version of Pathology In Practice along with regular news delivered to your inbox.